SNMMI: Follow-up PET/CT adds value in non-Hodgkin lymphoma management

Post-treatment PET/CT can help diagnose relapses of aggressive non-Hodgkin lymphoma (NHL) cases and spur additional treatment, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 annual meeting in Baltimore. {read more here}

Antibody fragments expand what PET imaging can ‘see’ in mice (video) – American Chemical Society

To visualize cancer throughout the body, physicians often turn to positron emission tomography (PET), which lights up areas that are metabolically active or growing, like tumors. Today in ACS Central Science, researchers report development of new PET probes composed of labeled antibody fragments that were tested in mice. These probes could someday be used to create targeted probes, giving doctors more information about tumors and how to treat them. {read more here}

­

In a prospective cohort study of 25 patients with prosthetic vascular graft infections treated with systemic antibiotics, the use of FDG-PET/CT for monitoring of metabolic activity within the graft was effective at determining infection status and was used to alter the course of antibiotic therapy in all patients. {read more here}

Reverse Radiology Where buyers and vendors win

Optimal management of lymph node-positive (cN+) prostate cancer (PCa) remains largely undefined given a lack of prospective, randomized data to inform practice. However, results from a recent study found patients at high-risk for prostate cancer significantly benefited from treatment with androgen deprivation therapy (ADT). {read more here}

Shop Parts